Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model
- PMID: 15979429
- DOI: 10.1016/j.amjcard.2005.02.040
Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model
Abstract
Although percutaneous coronary intervention (PCI) in the setting of cardiogenic shock has a high in-hospital mortality rate, it has been shown to decrease the mortality rate in certain subgroups. The identity and relative importance of variables that are predictive of in-hospital mortality rate after PCI for cardiogenic shock are uncertain. Accordingly, we examined data of >300,000 patients in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) that were collected from 1998 to 2002 and evaluated the outcomes in 483 consecutive patients who underwent emergency PCI for cardiogenic shock. Patients' mean age was 65 +/- 13 years, with men predominating (61%). All underwent emergency/salvage PCI in the setting of cardiogenic shock after acute myocardial infarction. Mean left ventricular ejection fraction was 30 +/- 16%. Stents were placed in 64% of patients, and thrombolytic agents were administered in 26%. Although PCI was angiographically successful in 79% of patients, the in-hospital mortality rate was 59.4%. Length of stay after PCI was 7.2 +/- 8 days. Logistic regression using all available variables identified 6 multivariate predictors of death: age (odds ratio [OR] 2.34, 95% confidence interval [CI] 1.68 to 3.28, p <0.001) for each 10-year increment, female gender (OR 1.55, 95% CI 1.00 to 2.41, p <0.001), baseline renal insufficiency (creatinine >2.0 mg/dl; OR 4.69, 95% CI 1.96 to 11.23, p <0.001), total occlusion in the left anterior descending artery (OR 1.99, 95% confidence interval 1.28 to 3.09, p <0.01), no stent used (OR 2.55, 95% CI 1.63 to 3.96, p <0.01), and no glycoprotein IIb/IIIa inhibitor used during PCI (OR 1.96, 95% CI 1.30 to 2.98, p <0.01). In a second analysis using only variables known to the clinician at the time of initial presentation, gender, age, renal insufficiency, and total occlusion of the left anterior descending coronary artery were significant. In conclusion, analysis of patients from the ACC-NCDR who underwent emergency PCI for acute myocardial infarction in the presence of cardiogenic shock shows an in-hospital mortality rate of approximately 60% when PCI is attempted.
Similar articles
-
Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.J Invasive Cardiol. 2007 May;19(5):217-23. J Invasive Cardiol. 2007. PMID: 17476036
-
[Mortality prognostic factors of cardiogenic shock complicating an acute myocardial infarction and treated by percutaneous coronary intervention].Ann Cardiol Angeiol (Paris). 2005 Mar;54(2):74-9. doi: 10.1016/j.ancard.2004.07.003. Ann Cardiol Angeiol (Paris). 2005. PMID: 15828461 French.
-
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).Eur Heart J. 2004 Feb;25(4):322-8. doi: 10.1016/j.ehj.2003.12.008. Eur Heart J. 2004. PMID: 14984921
-
Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?Am Heart J. 2010 Jan;159(1):141-7. doi: 10.1016/j.ahj.2009.10.035. Am Heart J. 2010. PMID: 20102880 Review.
-
[Emergency coronary surgery after transluminal angioplasty. Immediate results and long-term outcome of 100 operations].Arch Mal Coeur Vaiss. 1992 Jan;85(1):17-23. Arch Mal Coeur Vaiss. 1992. PMID: 1550431 Review. French.
Cited by
-
A review of cardiogenic shock in acute myocardial infarction.Curr Cardiol Rev. 2008 Feb;4(1):34-40. doi: 10.2174/157340308783565456. Curr Cardiol Rev. 2008. PMID: 19924275 Free PMC article.
-
Sex differences in treatments and outcomes of patients with cardiogenic shock: a systematic review and epidemiological meta-analysis.Crit Care. 2024 Jun 6;28(1):192. doi: 10.1186/s13054-024-04973-5. Crit Care. 2024. PMID: 38845019 Free PMC article.
-
The New Mayo Clinic Risk Score Characteristics in Acute Coronary Syndrome in Patients Following Percutaneous Coronary Intervention.J Tehran Heart Cent. 2017 Oct;12(4):149-154. J Tehran Heart Cent. 2017. PMID: 29576781 Free PMC article.
-
Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction-Associated Cardiogenic Shock.Struct Heart. 2022 Oct 31;6(6):100116. doi: 10.1016/j.shj.2022.100116. eCollection 2022 Nov. Struct Heart. 2022. PMID: 37288128 Free PMC article.
-
Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients.Catheter Cardiovasc Interv. 2017 May;89(6):955-963. doi: 10.1002/ccd.26701. Epub 2016 Aug 12. Catheter Cardiovasc Interv. 2017. PMID: 27515069 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous